CorPath® GRX Neuro Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT04236856
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
- Registry
-
NCT04236856
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Australia, Austria, Canada, France, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT04236856. Allocation not applicable; no masking; primary purpose treatment. Start 2020-08-21 (actual); primary completion 2022-04-23 (actual). Results posted on 2025-03-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CorPath® GRX Neuro Study
- Condition
- Intracranial Aneurysm
- Condition
- Subarachnoid Hemorrhage
- Condition
- Headache
- Intervention (Device)
- Robotic Endovascular Procedure
- Lead sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
Record details
- Record id
cardio:ct-nct04236856- Content hash
e3ba381022c4968b2ed11e6f95c5033d1f3856dc1c82e8e83e395e5331b62415